StockNews.com Begins Coverage on Integra LifeSciences (NASDAQ:IART)

StockNews.com began coverage on shares of Integra LifeSciences (NASDAQ:IART – Get Rating) in a report released on Thursday. The brokerage issued a buy rating on the life sciences company’s stock. A number of other brokerages also recently issued reports on IART. Truist Financial raised their price objective on Integra LifeSciences from $58.00 to $62.00 and […]

Related Keywords

Lisa Evoli ,Michaelj Mcbreen ,Integra Lifesciences ,Ronald Blue Trust Inc ,Integra Lifesciences Company Profile ,Citigroup ,Wipfli Financial Advisors ,Third Bancorp ,Fifth Third Bancorp ,Integra Lifesciences Holdings Corp ,Proficio Capital Partners ,Get Rating ,Blue Trust ,Financial Advisors ,Ivy Capital Management ,Lifesciences Holdings ,Codman Specialty Surgical ,Tissue Technologies ,Integra Lifesciences Daily ,Nasdaq Iart ,Tiart ,Medical ,45798520 ,Initiated Coverage ,Stocknews Com ,